Researchers analyzed data from more than 5000 adult cancer survivors to determine how common chronic pain is in this group.

Dyspareunia affects women of all ages with cancer, so assess pain location, intensity, and dryness, as well as partner ...

Among patients with psoriasis who have active or recent cancer, biologic therapies show similar cancer progression or recurrence and serious infection rates compared with conventional systemic agents.

A growing body of evidence suggests GLP-1 receptor agonists may improve survival as well as reduce chemotherapy-related toxicities in women with breast cancer.

Exposure to antibiotics during immune checkpoint inhibitor therapy may increase the risk for immune-related cutaneous adverse ...

Earlier this year, Australia rolled out its newest screening program in 20 years, but can it reach those most at risk?

FDA approval moves trastuzumab deruxtecan in combination with pertuzumab into frontline treatment of unresectable or ...

Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

Of women aged 40 years or older without breast cancer, 3% carry pathogenic variants in breast cancer risk genes — including many with no red flags in their family history.

Three oncology organizations weigh in on the CMS Medicare Physician Fee Schedule final rule for 2026, highlighting key pros ...

The third generation EGFR TKI targets EGFR mutant NSCLC, showing improved progression free survival and fewer adverse events ...

AFSOS 2025 introduced the first European reference for photobiomodulation, outlining the evidence, dosing, and clinical use in supportive cancer care.